A Randomized, Double-blind, Parallel Group, Multicentre Phase IIIb Study to Compare Ticagrelor With Clopidogrel Treatment on the Risk of Cardiovascular Death, Myocardial Infarction and Ischemic Stroke in Patients With Established Peripheral Artery Disease (EUCLID Examining Use of tiCagreLor In paD)
A Randomized, Double-blind, Parallel Group, Multicentre Phase IIIb Study to Compare Ticagrelor With Clopidogrel Treatment on the Risk of Cardiovascular Death, Myocardial Infarction and Ischemic Stroke in Patients With Established Peripheral Artery Disease (EUCLID Examining Use of tiCagreLor In paD)
The purpose of this study is to compare the effects of ticagrelor and clopidogrel in patients with Peripheral Artery Disease.
A randomized, double-blind, parallel group, multicentre phase IIIb study to compare ticagrelor with clopidogrel treatment on the risk of cardiovascular death, myocardial infarction and ischemic stroke in patients with established Peripheral Artery Disease (EUCLID Examining Use of tiCagreLor In paD)
Inclusion Criteria:
Exclusion Criteria:
CABA, 1428, Argentina
CABA, C1119ACN, Argentina
CABA, C1179AAB, Argentina
Rosario Santa Fe, S2000CVD, Argentina
North York, Ontario M3M 3E5, Canada
Haerbin, 150001, China
Ostrava-Dubina, 700 30, Czechia
Asahi-shi, 289-2511, Japan
Beppu-shi, 874-0011, Japan
Hamada-shi, 697-8511, Japan
Himeji-shi, 671-1227, Japan
Itabashi-ku, 173-8610, Japan
Kasuga-shi, 816-0864, Japan
Kishiwada-shi, 596-8522, Japan
Koriyama-shi, 963-8052, Japan
Matsubara-shi, 580-0032, Japan
Meguro-ku, 152-8902, Japan
Miura-gun, 240-0116, Japan
Ogori-shi, 838-0141, Japan
Sakaide-shi, 762-0007, Japan
Shinjuku-ku, 162-8655, Japan
Suwa-shi, 392-8510, Japan
Toyonaka-shi, 560-8565, Japan
Uji-shi, 611-0041, Japan
Yatsushiro-shi, 866-8533, Japan
Yokosuka-shi, 238-8567, Japan
Tg. Mures, 540124, Romania
Cheonan-si, 330-715, South Korea
Hospitalet de Llobregat(Barcel, 08907, Spain
Mallorca, 07120, Spain
Bangkoknoi, 10700, Thailand
Muang, 40002, Thailand
Hochiminh, Vietnam